Latest News about RHHBY
Recent news which mentions RHHBY
Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders
September 19, 2022
From Benzinga
From Benzinga
From Benzinga
A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know
September 12, 2022
From Benzinga
Why Regeneron Pharmaceuticals Stock Is Crushing It Today
September 08, 2022
From Motley Fool
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
From Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
August 25, 2022
From Benzinga
From Benzinga
From Benzinga
OTC Markets' Most Active Securities Sees A Shake-up In July
August 16, 2022
From Benzinga
FDA Approves Expanded Use Of Roche's Influenza Treatment
August 12, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Kiniksa Inks Global License Agreement With Roche For Vixarelimab
August 03, 2022
From Benzinga
From Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
From Motley Fool
From Benzinga
Why Shares of Agenus Inc. Rose 10.1% on Tuesday
July 26, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit
July 21, 2022
From Benzinga
From Benzinga
Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June
July 18, 2022
From Benzinga
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.